KA1164 |
(+)-Azasetron hydrochloride
|
123040-94-8 |
98% |
|
KA1282 |
(+)-Epibatidine dihydrochloride
|
166374-43-2 |
98% |
|
KA1221 |
(+)-ITD-1
|
1409968-46-2 |
98% |
|
KA1322 |
(+)-MDL 105725 - MDL 105725
|
189192-18-5 |
98% |
|
KA1611 |
(+)-PHNO hydrochloride - NA1agolide | Dopazinol
|
99705-65-4 |
98% |
|
KA1526 |
(+)-ZK 216348
|
669073-68-1 |
98% |
|
KA1165 |
(-)-Azasetron hydrochloride
|
123040-96-0 |
98% |
|
KA1442 |
(-)-MDL 105725
|
311348-81-9 |
98% |
|
KA1430 |
(-)-NPPCC
|
265644-16-4 |
98% |
|
KA1131 |
(-)-PD 128907 hydrochloride
|
112960-16-4 |
98% |
|
KA1243 |
(-)-WAY 100135 dihydrochloride - (R)-WAY 100135 dihydrochloride
|
149007-53-4 |
98% |
|
KA1502 |
(R)-(+)-5-methoxy-2-aminotetraline hydrochloride
|
58349-15-8 |
95% |
|
KA1110 |
(R)-(+)-7-Hydroxy-DPAT hydrobromide - (R)-7-OH-DPAT
|
1021878-34-1 |
98% |
|
KA1595 |
(R)-(+)-7-Methoxy-N-propyl-2-aminotetraline hydrochloride
|
93503-08-3 |
97% |
|
KA1542 |
(R)-(+)-8-Hydroxy-DPAT hydrobromide
|
78095-19-9 |
98% |
|
KA1146 |
(R)-(+)-8-Methoxy-2-aminotetraline hydrochloride
|
119363-61-0 |
98% |
|
KA1318 |
(R)-(-)-BMS 204352
|
187523-36-0 |
98% |
|
KA1403 |
(R)-(-)-LY 426965 dihydrochloride
|
228418-85-7 |
98% |
|
KA1259 |
(R)-(-)-N-Desmethyl-PK 11195
|
157809-85-3 |
98% |
|
KA1341 |
(R)-(-)-PK 11195
|
205934-46-9 |
98% |
|